Current and historical daily PE Ratio for CFMS (
Conformis Inc
) from 2015 to Oct 01 2023. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Conformis stock (CFMS) PE ratio as of Oct 01 2023 is 0.
More Details
Conformis Inc (CFMS) PE Ratio (TTM) Chart
Conformis Inc (CFMS) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1186
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Conformis PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2023-09-14 | At Loss | 2023-07-12 | At Loss |
| 2023-09-13 | At Loss | 2023-07-11 | At Loss |
| 2023-09-12 | At Loss | 2023-07-10 | At Loss |
| 2023-09-11 | At Loss | 2023-07-07 | At Loss |
| 2023-09-08 | At Loss | 2023-07-06 | At Loss |
| 2023-09-07 | At Loss | 2023-07-05 | At Loss |
| 2023-09-06 | At Loss | 2023-07-03 | At Loss |
| 2023-09-05 | At Loss | 2023-06-30 | At Loss |
| 2023-09-01 | At Loss | 2023-06-29 | At Loss |
| 2023-08-31 | At Loss | 2023-06-28 | At Loss |
| 2023-08-30 | At Loss | 2023-06-27 | At Loss |
| 2023-08-29 | At Loss | 2023-06-26 | At Loss |
| 2023-08-28 | At Loss | 2023-06-23 | At Loss |
| 2023-08-25 | At Loss | 2023-06-22 | At Loss |
| 2023-08-24 | At Loss | 2023-06-21 | At Loss |
| 2023-08-23 | At Loss | 2023-06-20 | At Loss |
| 2023-08-22 | At Loss | 2023-06-16 | At Loss |
| 2023-08-21 | At Loss | 2023-06-15 | At Loss |
| 2023-08-18 | At Loss | 2023-06-14 | At Loss |
| 2023-08-17 | At Loss | 2023-06-13 | At Loss |
| 2023-08-16 | At Loss | 2023-06-12 | At Loss |
| 2023-08-15 | At Loss | 2023-06-09 | At Loss |
| 2023-08-14 | At Loss | 2023-06-08 | At Loss |
| 2023-08-11 | At Loss | 2023-06-07 | At Loss |
| 2023-08-10 | At Loss | 2023-06-06 | At Loss |
| 2023-08-09 | At Loss | 2023-06-05 | At Loss |
| 2023-08-08 | At Loss | 2023-06-02 | At Loss |
| 2023-08-07 | At Loss | 2023-06-01 | At Loss |
| 2023-08-04 | At Loss | 2023-05-31 | At Loss |
| 2023-08-03 | At Loss | 2023-05-30 | At Loss |
| 2023-08-02 | At Loss | 2023-05-26 | At Loss |
| 2023-08-01 | At Loss | 2023-05-25 | At Loss |
| 2023-07-31 | At Loss | 2023-05-24 | At Loss |
| 2023-07-28 | At Loss | 2023-05-23 | At Loss |
| 2023-07-27 | At Loss | 2023-05-22 | At Loss |
| 2023-07-26 | At Loss | 2023-05-19 | At Loss |
| 2023-07-25 | At Loss | 2023-05-18 | At Loss |
| 2023-07-24 | At Loss | 2023-05-17 | At Loss |
| 2023-07-21 | At Loss | 2023-05-16 | At Loss |
| 2023-07-20 | At Loss | 2023-05-15 | At Loss |
| 2023-07-19 | At Loss | 2023-05-12 | At Loss |
| 2023-07-18 | At Loss | 2023-05-11 | At Loss |
| 2023-07-17 | At Loss | 2023-05-10 | At Loss |
| 2023-07-14 | At Loss | 2023-05-09 | At Loss |
| 2023-07-13 | At Loss | 2023-05-08 | At Loss |
Conformis Inc (CFMS) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Conformis Inc
NAICS : 339112
SIC : 3841
ISIN : US20717E1010
Description
Conformis Inc is a United States-based medical technology company. It uses the iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy. The company's iFit technology platform comprises three key elements which are iFit design, iFit printing, and iFit just-in-time delivery. It offers various partial and total knee replacement implants which include iTotal CR, iTotal PS, iDuo, and iUni. The company operates in the segment of the knee replacement market. Its total revenue is generated from the sale of its products to hospitals and other medical facilities. The majority of the company's revenue comes from the United States.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers